Target
mitochondrial metabolism
2 abstracts
Abstract
A phase I/II open-label clinical trial of CPI-613 in combination with modified FOLFIRINOX in patients with locally advanced (LAPC) or borderline resectable pancreatic cancer (BRPC).Org: Department of Nursing University Hospitals Seidman Cancer Center, Department of Nursing, University Hospitals Seidman Cancer Center / Case Western Comprehensive Cancer Center, University Hospitals, Case Medical Center - Seidman Cancer Center, Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Department of Surgery, University Hospitals Seidman Cancer Center,
Abstract
Aluminium phthalocyanine–mediated photodynamic therapy promotes antitumour activity in oesophageal cancer stem cells.Org: University of Johannesburg, Johannesburg, South Africa Health Product Regulatory Authority, Durban, South Africa,